Xenazine
Links shared publicly online about this topic
Long-Term Efficacy Of Xenazine® (Tetrabenazine) For The Treatment Of Chorea Associated With Huntington's Disease
medicalnewstoday.com — “Lundbeck Inc. has announced the presentation of results from an open-label extension study of Xenazine® (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). Da” View full resource at medicalnewstoday.com
Most Recently Shared on March 8, 2010 at 2:05 pm By:
Long-Term Efficacy Of Xenazine® (Tetrabenazine) For The Treatment Of Chorea Associated With Huntington's Disease http://mnt.to/3yBM
H. Lundbeck A/S (DK) - Third quarter report 2010 -- Continued strong growth in third quarter - 2010 results to be at the high end of guidance range - Drugs.com MedNews
drugs.com — “H. Lundbeck A S (Lundbeck) reports third quarter revenue of DKK 3,619 million, an increase of 7 compared to the third quarter results of 2009. Profit from opera” View full resource at drugs.com
Most Recently Shared on November 3, 2010 at 3:10 pm By:
H. Lundbeck A/S (DK) - Third quarter report 2010 -- Continued strong growth in third quarter - 2010 results t... http://bit.ly/afOYRc #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Depression News
The latest depression news published daily. Articles from research centers, universities and prestigious journals.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement

